FTO has been identified as a significant factor in a broad spectrum of human health issues, including obesity, diabetes mellitus, cardiovascular disorders, neurological anomalies, and various oncological conditions. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.